Simon Wöhrle

7PUBLICATIONS
31CO-AUTHORS
Molecular targetsWastewater treatment processesCancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 24, 2024
Ligandability assessment of the C-terminal Rel-homology domain of NFAT1.

Jark Böttcher, Julian E Fuchs, Moriz Mayer

|Oct 10, 2022
A selective and orally bioavailable VHL-recruiting PROTAC achieves SMARCA2 degradation in vivo.

Christiane Kofink, Nicole Trainor, Barbara Mair

|Dec 04, 2020
Getting a Grip on the Undrugged: Targeting β-Catenin with Fragment-Based Methods.

Dirk Kessler, Moriz Mayer, Stephan K Zahn

|Aug 14, 2019
SMARCA2-deficiency confers sensitivity to targeted inhibition of SMARCA4 in esophageal squamous cell carcinoma cell lines.

Katharina Ehrenhöfer-Wölfer, Teresa Puchner, Cornelia Schwarz

|Jul 04, 2019
Publisher Correction: BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design.

William Farnaby, Manfred Koegl, Michael J Roy

|Jun 11, 2019
BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design.

William Farnaby, Manfred Koegl, Michael J Roy

Pageof 2